593345 The present disclosure relates to antimicrobial compositions and more specifically compositions of a quinolone carboxylic acid derivative (delafloxacin) with a cyclodextrin. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.